Robeco Institutional Asset Management
EVH icon

Robeco Institutional Asset Management’s Evolent Health EVH Stock Holding History

Robeco Institutional Asset Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-24,221
Closed -$870K – 975
2022
Q3 		$870K Buy
+24,221
New +$853K ﹤0.01% 712

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

Robeco Institutional Asset Management's EVH Position: Q4 2022 in Review

Robeco Institutional Asset Management sold out of Evolent Health (EVH) in Q4 2022, closing a stake of 24,221 shares — an estimated $870K sold.

Robeco Institutional Asset Management first reported a position in EVH in Q3 2022 and held it in 1 quarter. The position peaked at $870K in Q3 2022. 231 funds tracked by Wall St. Rank hold EVH as of Q4 2022.

  • Robeco Institutional Asset Management reported no remaining Evolent Health position as of Q4 2022 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 24,221 Evolent Health shares in Q4 2022, an estimated $870K.
  • Robeco Institutional Asset Management first reported a position in Evolent Health in Q3 2022 and held it in 1 quarter.
  • Robeco Institutional Asset Management's Evolent Health position peaked at $870K in Q3 2022.
  • 231 funds tracked by Wall St. Rank held Evolent Health as of Q4 2022.

Based on Robeco Institutional Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.